Literature DB >> 9533454

Albendazole.

P Venkatesan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9533454     DOI： 10.1093/jac/41.2.145

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  36 in total

1.  Cysticercosis.

Authors:  J F Bale
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

2.  Loss of body hair as a side effect of albendazole.

Authors:  Adnan Tas; Seyfettin Köklü; Hacer Celik
Journal:  Wien Klin Wochenschr       Date:  2012-03       Impact factor: 1.704

3.  Diffuse unilateral subacute neuroretinitis in the United Kingdom.

Authors:  Evelyne Oueghlani; Eoin O'Sullivan; Carlos E Pavesio
Journal:  Int Ophthalmol       Date:  2010-03-25       Impact factor: 2.031

4.  Synthesis and characterization of thiolated carboxymethyl chitosan-graft-cyclodextrin nanoparticles as a drug delivery vehicle for albendazole.

Authors:  Ghazaleh Alamdarnejad; Alireza Sharif; Shahrouz Taranejoo; Mohsen Janmaleki; Mohammad Reza Kalaee; Mohsen Dadgar; Mazyar Khakpour
Journal:  J Mater Sci Mater Med       Date:  2013-05-12       Impact factor: 3.896

5.  Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.

Authors:  Gianfranco Arroyo; Javier A Bustos; Andres G Lescano; Isidro Gonzales; Herbert Saavedra; Silvia Rodriguez; E Javier Pretell; Pierina S Bonato; Vera L Lanchote; Osvaldo M Takayanagui; John Horton; Armando E Gonzalez; Robert H Gilman; Hector H Garcia
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

Review 6.  Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.

Authors:  Gerald S Murphy; Stuart Johnson
Journal:  Hawaii J Med Public Health       Date:  2013-06

7.  Small molecule screen for compounds that affect vascular development in the zebrafish retina.

Authors:  Satish S Kitambi; Kyle J McCulloch; Randall T Peterson; Jarema J Malicki
Journal:  Mech Dev       Date:  2009 May-Jun       Impact factor: 1.882

8.  Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.

Authors:  Hector H Garcia; Isidro Gonzales; Andres G Lescano; Javier A Bustos; Mirko Zimic; Diego Escalante; Herbert Saavedra; Martin Gavidia; Lourdes Rodriguez; Enrique Najar; Hugo Umeres; E Javier Pretell
Journal:  Lancet Infect Dis       Date:  2014-07-03       Impact factor: 25.071

9.  Immunomodulative effect of glucan and/or glucan supplemented with zinc in albendazole therapy for murine alveolar echinococcosis.

Authors:  Jarmila Porubcová; Emília Dvoroznáková; Zuzana Sevcíková
Journal:  Parasitol Res       Date:  2007-05-12       Impact factor: 2.289

10.  The efficacy of therapy with albendazole in mice with parasitic meningitis caused by Angiostrongylus cantonensis.

Authors:  K P Lan; C J Wang; S C Lai; K M Chen; S S Lee; J D Hsu; H H Lee
Journal:  Parasitol Res       Date:  2004-06-04       Impact factor: 2.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.